Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $23.28 USD
Change Today -0.15 / -0.64%
Volume 314.6K
WMGI On Other Exchanges
Symbol
Exchange
NASDAQ GS
Frankfurt
NASDAQ GM
As of 8:10 PM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

wright medical group inc (WMGI) Snapshot

Open
$23.36
Previous Close
$23.43
Day High
$23.55
Day Low
$23.18
52 Week High
10/29/14 - $32.65
52 Week Low
08/21/15 - $22.17
Market Cap
1.2B
Average Volume 10 Days
436.0K
EPS TTM
$-4.21
Shares Outstanding
51.4M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for WRIGHT MEDICAL GROUP INC (WMGI)

wright medical group inc (WMGI) Related Businessweek News

No Related Businessweek News Found

wright medical group inc (WMGI) Details

Wright Medical Group, Inc., a specialty orthopaedic company, provides extremity and biologic solutions that enable clinicians to alleviate pain and restore their patients’ lifestyles worldwide. The company offers products that are used primarily in foot and ankle repair, upper extremity products, and biologics products. Its extremity hardware products include implants and other devices to replace or reconstruct injured or diseased joints and bones of the foot, ankle, hand, wrist, fingers, toes, elbow, and shoulder. The company also provides biologic products, which are used to support treatment of damaged or diseased bone, and tendons and soft tissues; and other biological solutions for surgeons and their patients, as well as offers a bone graft product incorporating antibiotic delivery. Its biological products focus on supporting biological musculoskeletal repair by utilizing synthetic and human tissue-based materials. The company sells its products through a network of employee sales representatives, independent sales representatives, and stocking distributors. Wright Medical Group, Inc. was founded in 1950 and is headquartered in Memphis, Tennessee.

1,180 Employees
Last Reported Date: 02/26/15
Founded in 1950

wright medical group inc (WMGI) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $750.0K
Chief Financial Officer and Senior Vice Presi...
Total Annual Compensation: $354.6K
Chief Operating Officer and Executive Vice Pr...
Total Annual Compensation: $500.0K
President of U.S. Extremities
Total Annual Compensation: $641.0K
President of International
Total Annual Compensation: $564.0K
Compensation as of Fiscal Year 2014.

wright medical group inc (WMGI) Key Developments

Wright Medical Group, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015; Provides Earnings Guidance for the Full Year of 2015

Wright Medical Group Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported net sales of $80,420,000 against $72,364,000 a year ago. Operating loss was $34,342,000 against $29,171,000 a year ago. Loss from continuing operations before income taxes was $37,148,000 against $51,613,000 a year ago. Net loss from continuing operations was $37,306,000 or $0.73 basic and diluted per share against $53,583,000 or $1.08 basic and diluted per share a year ago. Net loss was $44,315,000 or $0.87 basic and diluted per share against $56,226,000 or $1.13 basic and diluted per share a year ago. International net sales were $22,150,000. Operating loss, as adjusted was $22,167,000 against $21,990,000 a year ago. EBITDA was $18,206,000 against $40,167,000 a year ago. Adjusted EBITDA was $10,865,000 against $11,565,000 a year ago. Loss before taxes, as adjusted was $27,085,000 against $23,638,000 a year ago. Net loss from continuing operations, as adjusted was $27,270,000 or $0.53 diluted per share against $23,962,000 or $0.48 diluted per share a year ago. Net cash used in operating activities was $25,754,000 against $24,350,000 a year ago. Capital expenditures were $13,900,000 against $16,448,000 a year ago. Net sales representing an 11% increase as reported and 15% increase on a constant currency basis compared to the second quarter of 2014. For the six months, the company reported net sales of $158,354,000 against $143,426,000 a year ago. Operating loss was $67,463,000 against $52,217,000 a year ago. Loss from continuing operations before income taxes was $83,230,000 against $94,081,000 a year ago. Net loss from continuing operations was $83,554,000 or $1.64 basic and diluted per share against $83,881,000 or $1.71 basic and diluted per share a year ago. Net loss was $94,063,000 or $1.85 basic and diluted per share against $86,646,000 or $1.76 basic and diluted per share a year ago. International net sales were $42,598,000. Operating loss, as adjusted was $44,212,000 against $36,488,000 a year ago. EBITDA was $48,745,000 against $72,071,000 a year ago. Adjusted EBITDA was $22,703,000 against $17,752,000 a year ago. Loss before taxes, as adjusted was $52,821,000 against $40,004,000 a year ago. Net loss from continuing operations, as adjusted was $53,172,000 or $1.04 diluted per share against $40,520,000 or $0.82 diluted per share a year ago. Net cash used in operating activities was $51,000,000 against $51,590,000 a year ago. Capital expenditures were $25,754,000 against $24,284,000 a year ago. The company provided earnings guidance for the full year of 2015. For the year, the company continues to anticipate net sales of approximately $325 million to $335 million, representing constant currency growth of 13% to 16% from 2014. The company continues to anticipate 2015 adjusted negative EBITDA from continuing operations, as described in the GAAP to non-GAAP reconciliation provided later in this release, of $22.0 million to $27.0 million. The company continues to anticipate adjusted loss per share from continuing operations, including stock-based compensation, for full-year 2015 of $1.67 diluted per share to $1.77 diluted per share, based on approximately 51.1 million shares outstanding. While the amount of the non-cash stock-based compensation charges will vary depending upon a number of factors, the company currently estimates that the after-tax impact of those expenses will be approximately $0.24 per diluted share for the full-year 2015. The company's anticipated ranges for net sales, earnings and adjusted EBITDA from continuing operations are forward-looking statements, as are any other statements that anticipate or aspire to future events or performance. They are subject to various risks and uncertainties that could cause the company's actual results to differ materially from the anticipated targets. The anticipated targets are not predictions of the company's actual performance.

Tornier N.V., Wright Medical Group Inc., Special/Extraordinary Shareholders Meeting, Jun 18, 2015

Tornier N.V., Wright Medical Group Inc., Special/Extraordinary Shareholders Meeting, Jun 18, 2015., at 09:30 Central European Standard Time. Location: Prins Bernhardplein 200. Agenda: To consider shareholder approval of the proposed merger and the issuance of Tornier ordinary shares in connection with the merger in accordance with Dutch law; to consider change in the corporate name to Wright Medical Group N.V.; and to consider the election of new directors effective upon completion of the merger.

Wright Medical Group Inc. Announces Unaudited Consolidated Earnings Results for the First Quarter Ended March 31, 2015; Reaffirms Earnings Guidance for the Full Year 2015

Wright Medical Group Inc. announced unaudited consolidated earnings results for the first quarter ended March 31, 2015. For the quarter, the company net sales totaled $77.9 million during, representing a 10% increase as reported and 14% increase on a constant currency basis compared to the first quarter of 2014. Net loss from continuing operations totaled $46.2 million or $0.91 per diluted share, compared to net loss of $30.3 million or $0.62 per diluted share in the first quarter of 2014. The company's adjusted EBITDA from continuing operations, as defined in the GAAP to non-GAAP reconciliation provided later in this release, were negative $11.8 million, compared to negative $6.2 million in the same quarter of the prior year. Loss from continuing operations before income taxes was $46.082 million compared to $42.468 million a year ago. Net loss was $49.748 million or $0.98 per diluted share compared to $30.420 million or $0.63 per diluted share a year ago. Operating loss was $33.121 million compared to $23.046 million a year ago. Operating loss, as adjusted was $22.045 million compared to $14.498 million a year ago. LBITDA was $30.539 million compared to $31.904 million a year ago. Net loss, as adjusted was $25.902 million or $0.51 per diluted share compared to $16.558 million or $0.34 per diluted share a year ago. Net cash used in operating activities was $25.246 million compared to $27.240 million a year ago. Capital expenditures were $11.854 million compared to $7.836 million a year ago. The company continues to anticipate net sales for 2015 of approximately $325 million to $335 million, representing constant currency growth of 13% to 16% from 2014. The company continues to anticipate 2015 adjusted EBITDA from continuing operations, as described in the GAAP to non-GAAP reconciliation provided later in this release, of negative $22.0 million to negative $27.0 million. The company continues to anticipate adjusted earnings per share from continuing operations, including stock-based compensation, for full-year 2015 of $1.67 to $1.77 per diluted share, based on approximately 51.1 million shares outstanding.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
WMGI:US $23.28 USD -0.15

WMGI Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cyberonics Inc $67.00 USD +0.19
ICU Medical Inc $113.92 USD +0.47
Orthofix International NV $38.08 USD +0.70
RTI Surgical Inc $6.33 USD +0.04
Tornier NV $22.29 USD -0.25
View Industry Companies
 

Industry Analysis

WMGI

Industry Average

Valuation WMGI Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 3.8x
Price/Book 5.6x
Price/Cash Flow NM Not Meaningful
TEV/Sales 0.7x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact WRIGHT MEDICAL GROUP INC, please visit www.wmt.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.